• Skip to primary navigation
  • Skip to main content
Neural Stem Cell Institute, Rensselaer NY

Neural Stem Cell Institute, Rensselaer NY

Stem cell research and applications in the treatment of diseases like Retinitis Pigmentosis, Alzheimer's, Parkinson's, Spinal Cord Injury, Retinal Degeneration. Home of SallyTemple's lab.

  • Home
  • Support NSCI
  • Research
    • Alzheimer’s Program
    • Retinal Disease: Age-Related Macular Degeneration
    • Parkinson’s Disease Program
    • Spinal Cord Injury Program
    • Computing @ NSCI
  • NeuraCell
  • Tau Consortium
  • News
  • About Us
    • Our Team
  • Contact Us
    • Careers
    • Volunteer Internship
    • Collaboration Inquiries
    • Media Inquiries
  • Show Search
Hide Search

Dr. Messer hosts webinar for “The Scientist”

Tom Kiehl · April 18, 2018 · Leave a Comment

Dr. Anne Messer was one of two experts chosen to present a webinar for The Scientist (March 8, 2018.) Antibodies are the fastest growing class of synthetic therapeutics, and Dr. Messer’s presentation covered their development and use as therapeutics and markers for neurodegenerative diseases. She described cutting-edge design and optimization approaches, as well as offering insight on future directions in antibody engineering. Human stem cell lines and assays at NSCI allow screening and testing for which of these engineered antibodies and their variants should be carried forward as clinical drug candidates. The session had 581 registrants and 148 live viewers who also asked questions at the end of the presentations.

https://www.the-scientist.com/?articles.view/articleNo/51539/title/Trends-in-Synthetic-Biology–Antibody-Engineering/

Uncategorized

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Neural Stem Cell Institute, Rensselaer NY

Copyright © 2025 - This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

  • Home
  • Support NSCI
  • Research
  • NeuraCell
  • Tau Consortium
  • News
  • About Us
  • Contact Us